Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

上 海 復 星 醫 藥( 集 團 )股 份 有 限 公 司

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

(a joint stock limited company incorporated in the People's Republic of China with limited liability)

(Stock Code: 02196)

CHANGE OF JOINT COMPANY SECRETARY AND

AUTHORISED REPRESENTATIVE

The board (the ''Board'') of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (the ''Company'') hereby announces that due to work re-arrangement, Ms. Lo Yee Har, Susan (''Ms. Lo'') resigned as (i) a joint company secretary of the Company (the ''Joint Company Secretary''); and (ii) an authorised representative of the Company (the ''Authorised Representative'') under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the ''Hong Kong Stock Exchange''), with effect from 17 December 2019.

Ms. Lo confirmed that she had no disagreement with the Board and there were no other matters in respect of her resignation that need to be brought to the attention of the shareholders of the Company.

The Board further announces the appointment of Ms. Kam Mei Ha, Wendy (''Ms. Kam'') as a Joint Company Secretary and an Authorised Representative with effect from 17 December 2019. Ms. Kam will serve as the Joint Company Secretary to assist Ms. Dong Xiaoxian, another existing Joint Company Secretary and perform duties of Authorised Representative with Mr. Chen Qiyu.

Ms. Kam, aged 52, is an executive director of corporate services at Tricor Services Limited. Prior to joining Tricor Services Limited, Ms. Kam served as manager of the company secretarial department of Ernst & Young, Hong Kong and Tricor Tengis Limited. Ms. Kam is named company secretary of five listed companies on the Hong Kong Stock Exchange (including the Company). Ms. Kam is a Chartered Secretary, a Chartered Governance Professional and a fellow of both The Hong Kong Institute of Chartered Secretaries (HKICS) and The Chartered Governance Institute (formerly known as The Institute of Chartered Secretaries and Administrators (ICSA)). Ms. Kam is also a member of the customer liaison group of the Hong Kong Companies Registry. She graduated from City Polytechnic of Hong Kong (now known as City University of Hong Kong) with a professional diploma in company secretaryship and administration in November 1990.

- 1 -

The Board would like to take this opportunity to express its sincere gratitude to Ms. Lo for her valuable contributions to the Company during her tenure of office as a Joint Company Secretary and an Authorised Representative and to extend our warm welcome to Ms. Kam for her new appointment.

By order of the Board

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.*

Chen Qiyu

Chairman

Shanghai, PRC

17 December 2019

As at the date of this announcement, the executive directors of the Company are Mr. Chen Qiyu, Mr.Yao Fang and Mr. Wu Yifang; the non-executive directors of the Company are Mr. Xu Xiaoliang, Mr.Wang Can, Ms. Mu Haining and Mr. Liang Jianfeng; and the independent non-executive directors of the Company are Mr. Jiang Xian, Dr. Wong Tin Yau Kelvin, Ms. Li Ling and Mr. Tang Guliang.

  • for identification purposes only

- 2 -

Attachments

  • Original document
  • Permalink

Disclaimer

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 17 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 December 2019 11:15:00 UTC